Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOCARNITINE vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOCARNITINE vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOCARNITINE LEVOMILNACIPRAN
Total FAERS Reports 392 1,378
Deaths Reported 91 382
Death Rate 23.2% 27.7%
Hospitalizations 183 378
Average Patient Age 40.9 yrs 46.4 yrs
% Female Patients 52.6% 80.2%
FDA Approval Date Apr 10, 1986 Feb 4, 2019
Manufacturer Saptalis Pharmaceuticals, LLC Allergan, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription